Equine Healthcare Market Size, Share and Growth Outlook, 2026

Equine Healthcare Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Equine Healthcare Market size is forecast to increase from $4.78 Billion in 2026 to $11.34 Billion in 2034 at a CAGR of 11.4% between 2026 and 2034.

The Equine Healthcare market report provides detailed analysis and outlook of Equine Healthcare segments including By Product Category (Pharmaceuticals, Biologics & Vaccines, Therapeutics & Regenerative Medicine, Diagnostic Kits, Imaging Systems, & Consumables, Medical Feed Additives & Supplements, Veterinary Practice Management Software & Digital Solutions), By Clinical Indication (Musculoskeletal & Orthopedic Disorders, Parasitic, Bacterial, & Fungal Infections, Respiratory & Metabolic Conditions, Equine Viruses, Gastrointestinal & Colic Conditions), By Equine Activity Type (Competitive Sports & Racing, Recreation, Leisure, & Companion Care, Agricultural & Working Use), By End-User (Veterinary Outpatient Clinics, Specialized Inpatient Equine Hospitals, Equestrian Facilities & Professional Breeding Farms, Research Labs & Academic Medical Centers), By Distribution Channel (Direct Institutional Sales & Distributors, Retail Outlets & Veterinary Pharmacies, Veterinary E-Commerce Platforms) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Equine Healthcare Industry Overview

Artificial Intelligence Enhancing Equine Diagnostic Capabilities

The equine healthcare industry is increasingly embracing artificial intelligence to improve diagnostic accuracy and clinical decision-making. Boehringer Ingelheim, in collaboration with equine technology specialist Sleip, has expanded deployment of an AI-powered lameness assessment platform designed to support veterinarians in evaluating musculoskeletal conditions. The technology utilizes advanced video analysis to assess gait patterns, movement asymmetry, and biomechanical performance metrics with greater objectivity than traditional visual examinations alone. By enabling earlier detection of subtle locomotion abnormalities, the platform supports timely intervention, personalized rehabilitation strategies, and improved long-term management of equine orthopedic health. The integration of AI-driven analytics into veterinary medicine reflects a broader digital transformation occurring throughout the equine healthcare ecosystem.

Collaborative Research Advancing Equine Health and Welfare

Industry-wide collaboration is becoming a major driver of innovation in equine healthcare and animal welfare. The European Partnership on Animal Health and Welfare (EUPAH&W) launched a major multinational research and innovation initiative focused on advancing animal health solutions and welfare standards. Supported by organizations across numerous countries, the program emphasizes improving welfare during livestock and equine transportation while accelerating the development of innovative vaccines and therapeutic interventions. A key objective is reducing reliance on antimicrobials through preventive healthcare strategies and enhanced disease management practices. These collaborative efforts are fostering the development of evidence-based veterinary solutions that improve animal health outcomes while addressing evolving regulatory and sustainability priorities within the global equine sector.

Long-Acting Therapeutics Transforming Equine Disease Management

Pharmaceutical innovation continues to reshape treatment approaches for common equine health conditions. Hyloris Pharmaceuticals is advancing HY-095, a long-acting injectable proton pump inhibitor developed for the management of Equine Gastric Ulcer Syndrome (EGUS), one of the most prevalent gastrointestinal disorders affecting performance and leisure horses. Unlike traditional oral omeprazole formulations that require strict daily administration schedules, the injectable therapy is designed to provide extended drug exposure while reducing dosing frequency. This approach has the potential to improve treatment compliance, simplify disease management protocols, and reduce labor requirements for veterinary hospitals, breeding facilities, and racing stables. The development of long-acting veterinary therapeutics reflects growing demand for convenient, effective, and precision-focused healthcare solutions within the equine healthcare industry.

Equine Healthcare Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Equine Healthcare market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Zoetis Inc., Merck Animal Health (MSD Animal Health), Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac Group, Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Vetoquinol S.A., Heska Corporation (Antech Diagnostics / Mars). The Equine Healthcare market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Equine Healthcare industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Equine Healthcare Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Equine Healthcare companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Equine Healthcare markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Equine Healthcare Market Competitive Benchmarking and Company Analysis

Leading companies in Equine Healthcare industry include- Zoetis Inc., Merck Animal Health (MSD Animal Health), Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Ceva Santé Animale, Virbac Group, Dechra Pharmaceuticals PLC, IDEXX Laboratories, Inc., Vetoquinol S.A., Heska Corporation (Antech Diagnostics / Mars). The Equine Healthcare market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Equine Healthcare Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Equine Healthcare market remains one of the strongest-performing segments in the country.
The US Equine Healthcare Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Equine Healthcare market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Equine Healthcare industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Equine Healthcare markets

Canada's strong Equine Healthcare sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Equine Healthcare market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Equine Healthcare Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Equine Healthcare market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Equine Healthcare population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Equine Healthcare industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Equine Healthcare market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Equine Healthcare sales through 2034

France Equine Healthcare companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Equine Healthcare Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Equine Healthcare distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Equine Healthcare Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Equine Healthcare market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Equine Healthcare industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Equine Healthcare industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Equine Healthcare Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Equine Healthcare market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Equine Healthcare market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Equine Healthcare Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Equine Healthcare Market Segmentation

By Product Category
Pharmaceuticals
Biologics & Vaccines
Therapeutics & Regenerative Medicine
Diagnostic Kits, Imaging Systems, & Consumables
Medical Feed Additives & Supplements
Veterinary Practice Management Software & Digital Solutions
By Clinical Indication
Musculoskeletal & Orthopedic Disorders
Parasitic, Bacterial, & Fungal Infections
Respiratory & Metabolic Conditions
Equine Viruses
Gastrointestinal & Colic Conditions
By Equine Activity Type
Competitive Sports & Racing
Recreation, Leisure, & Companion Care
Agricultural & Working Use
By End-User
Veterinary Outpatient Clinics
Specialized Inpatient Equine Hospitals
Equestrian Facilities & Professional Breeding Farms
Research Labs & Academic Medical Centers
By Distribution Channel
Direct Institutional Sales & Distributors
Retail Outlets & Veterinary Pharmacies
Veterinary E-Commerce Platforms

Top Companies in Equine Healthcare Industry

Zoetis Inc.
Merck Animal Health (MSD Animal Health)
Boehringer Ingelheim International GmbH
Elanco Animal Health Incorporated
Ceva Santé Animale
Virbac Group
Dechra Pharmaceuticals PLC
IDEXX Laboratories, Inc.
Vetoquinol S.A.
Heska Corporation (Antech Diagnostics / Mars)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

MoCRA Compliance as a Competitive Advantage in the US

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025